Science for Life Drug Discovery Resources at Purdue Andrew Mesecar, PhD Deputy Director, Purdue Center for Cancer Research Walther Professor of Cancer Structural Biology Department of Biological Sciences and Department of Chemistry iCTSI - Molecular Therapeutics & Drug Discovery – April 21 st , 2014
10
Embed
Science for Life Drug Discovery Resources at Purdue Andrew Mesecar, PhD Deputy Director, Purdue Center for Cancer Research Walther Professor of Cancer.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Science for Life
Drug Discovery Resources at Purdue
Andrew Mesecar, PhDDeputy Director, Purdue Center for Cancer ResearchWalther Professor of Cancer Structural BiologyDepartment of Biological Sciences and Department of Chemistry
iCTSI - Molecular Therapeutics & Drug Discovery – April 21st, 2014
• Biomol. Screening**• Comp. Chemistry• Medicinal Chemistry• NMR• Mass Spectrometry
• DNA Sequencing• Proteomics*• Metabolite Profiling*• Transgenic Mouse* • BioInformatics
ChemBridge DiverSet (30,000) ChemBridge CNS Set (20,000) ChemBridge NovaCore (50,000) Asinex Lead/Drug Like (60,000) LifeChemicals Cherry Picked (30,000) ChemBridge-Cherry Picked (25,000) ASDI Lead/Drug Like (6,800) ChemDiv Fragment (2,000) LOPAC1280 Pharma Active (1,280) Collaboration compounds (>1,000) Natural product library (~1,500)
Format96-well and 384-well at 10 mM in DMSODelivery with Pin Tools 200 nL or 6 nL
Purdue Compound Libraries (~220K)
Filling in ‘Chemical Space’ Compound Library Design & Sharing with Notre Dame and IU
Chemical Space Coverage of Purdue and IU Compound Libraries. 3D Principle-component analysis of Drug-Like Properties. Only the portions of the library closest in chemical space to the compounds in the LOPAC® library are shown.
DrugDiscovery.Purdue.edu
Dr. Sergey Savinov
College of Science-IT and Purdue ITaP Provide Database and Server Maintenance
Computational and Medicinal Chemistry Shared Resource
Computational and Medicinal Chemistry Shared Resource
Compound Database –Web-based Oracle database using Dotmatics suite of programs (Browser)
Cheminformatics Analysis (Compound Cluster & Substructure Analysis) –Extensive Analysis Suite of Programs via Dotmatics software platform (Browser, Vortex, Gateway, Studies, Notebook, Nucleus, Pinpoint) or Canvas in the Schrödinger Small Molecular Suite of Programs
Enhanced Services that can be used in Conjunction with HTS
Protein Structural Analysis & Homology Modeling In silico screening – Against our in-house 220K compound library, Zinc database
etc. Can provide enrichment factor for choosing libraries and individual plates to test. Schrödinger Small Molecular Suite of Programs
Basic Services Included with HTS in Biomolecular Screening Facility in Bindley
Cheminformatics and Structure-Based Design component was Established in 2012 via funding from Center for Cancer Research, Walther Cancer Foundation (Mesecar Grant) Discovery Park and Indiana CTSI
Antonella Pepe, PhD
Post-Doctorate Research with Professor Gunda GeorgDepartment of Medicinal Chemistry, Univ. Minnesota
Graduate Work with Prof. Iwao OjimaChemistry Department, SUNY Stony Brook
Formally at Frederick National Laboratory for Cancer Research - National Institutes of Health
Medicinal Chemistry Core Component was Established October 21st, 2013 with support from the Walther Cancer Foundation.
Support of HTS, hit-2-lead follow-up (SAR) and scale-up for animal studies.
Long-term, this shared resource will expand to include non-cancer related projects to support Purdue and CTSI faculty as a campus and CTSI resource.
Computational and Medicinal Chemistry Shared Resource
Drug Discovery and Development at Purdue
High-Throughput Crystallization, Crystal Imaging and Crystal Optimization
Lead Optimization – Macromolecular Crystallography Shared ResourceDr. Nic Steussy (PCCR) & Dr. Dinesh Yernool (Bindley Biosciences)
LS-CAT
High-Throughput X-ray Data Collection
LRL-CAT
10
Accelerating New Collaborations and Navigating Through Shared Resources for Drug Discovery